Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • msxakk
    Junior Member
    • Jul 2015
    • 1

    #1

    Meaning of differential promoter use (cuffdiff)

    Hi All,

    Can somebody explain to me how is differential promoter use inferred from RNAseq data ? Here I'm talking about the way it is implemented by cuffdiff (I followed TUXEDO pipeline). In the documentation it says:

    " This tab delimited file lists, for each gene, the amount of overloading detected among its primary transcripts, i.e. how much differential promoter use exists between samples. Only genes producing two or more distinct primary transcripts (i.e. multi-promoter genes) are listed here. "

    What is considered a primary transcript? Is it equivalent to pre-mRNA ? If my library is poly(A) enriched it shouldn't be rich for pre-mRNAs yet I still get a result (TEST STATUS OK) for some of the genes. I understand that poly(A) enrichment is not ideal and hence there could have been some reads derived from pre-mRNAs but in that case I would have been limited by stochastic forces ? Hence making comparisons between conditions would be challenging. And finally why would differential levels of pre-mRNA indicate differential promoter usage and why only genes producing two or more distinct primary transcripts would be included in analysis while the rest would not?

    Thanks
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Crossposted to BioStars: https://www.biostars.org/p/151531/

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Working...